Zealand Pharma Announces Pipeline Update
Copenhagen, 2013-03-08 08:28 CET (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) announces updates to its portfolio of partnered and proprietary peptide medicines and drug candidates including commercial and development progress, and clinical decisions.